NDC 51672-1365-04 - Fluocinolone Acetonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1365
- Requested NDC
- 51672-1365-04
- Package NDCs from labels
- 51672-1365-2, 51672-1365-4, 51672-1365-04
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fluocinolone Acetonide Topical Solution USP, 0.01% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1365-2 | Fluocinolone Acetonide | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 51672-1365-2 | Fluocinolone Acetonide | 20 mL in 1 BOTTLE | SOLUTION | 20 | 3 | |
| 51672-1365-4 | Fluocinolone Acetonide | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 51672-1365-4 | Fluocinolone Acetonide | 60 mL in 1 BOTTLE | SOLUTION | 60 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1365 | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | Current NDC, Legacy NDC, 4 package rows | 20170421_02352ed1-3568-441f-add8-45201351a11c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1365-4 | ML - Milliliter | 51672-1365 | bf5c5a2c-bf1b-450d-94e6-4e47bbabbbe9 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| fluocinolone acetonide | ACTIVE INGREDIENT | 0CD5FD6S2M | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| fluocinolone acetonide | ACTIVE MOIETY | 0CD5FD6S2M | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SYSTANE HYDRATION PF PRESERVATIVE FREE | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | db3a6c68-320b-46b0-83fa-6c29297a84a6 | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | Alcon Research Ltd | 14916d2c-a63d-491e-bd91-a61f300af38a | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane Lubricant | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 15bc06ec-f3dc-3180-ca1a-106769a770ea | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane ULTRA | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a5c1c194-3db5-4f18-9cd1-97f7f84c3cff | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 7eaa93ca-c843-4c89-921b-c76659410dce | 2023-12-14 | Warnings | 6DC9Q167V3 |
| GenTeal Tears Gel Drops | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 84388a75-9d11-48ce-bf5a-88f0580d2d03 | 2023-12-14 | Warnings | 6DC9Q167V3 |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| Synalar | FLUOCINOLONE ACETONIDE | Medimetriks Pharmaceuticals, Inc. | d2d155cf-a635-4ab7-87de-34e90b9a74cd | 2023-11-29 | Adverse reactions | 0CD5FD6S2M |
| Fluocinolone Acetonide | FLUOCINOLONE ACETONIDE | Cosette Pharmaceuticals, Inc. | de5b78ab-ff79-3e0f-cad4-ecab11ebbdcd | 2023-11-22 | Adverse reactions | 0CD5FD6S2M |
| Phexxi | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 173ff411-7227-47b0-94dc-844e1ebaf14e | 2023-11-21 | Warnings, Adverse reactions | 2968PHW8QP |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 6DC9Q167V3 |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 6DC9Q167V3 |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 6DC9Q167V3 |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 6DC9Q167V3 |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 6DC9Q167V3 |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | 6DC9Q167V3 |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 6DC9Q167V3 |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 6DC9Q167V3 |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 6DC9Q167V3 |
| Anubis Barcelona Regul OIl | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ARCTIUM MAJUS ROOT EXTRACT | ANUBIS COSMETICS SL | eb905bd0-c600-b8b2-e053-2995a90ad259 | 2023-09-01 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.